| Shannon Golub, LMSW | |
|
3930 Knowles Ave Ste 200, Kensington, MD 20895-2428 | |
| (513) 702-4366 | |
| Not Available |
| Full Name | Shannon Golub |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 3930 Knowles Ave Ste 200, Kensington, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1063190544 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 30159 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Shannon Golub, LMSW 5710 Mohican Pl, Bethesda, MD 20816-1055 Ph: (513) 702-4366 | Shannon Golub, LMSW 3930 Knowles Ave Ste 200, Kensington, MD 20895-2428 Ph: (513) 702-4366 |
News Archive
"At this critical time when we are concerned about our country's financial well being it is imperative that we curtail our charity to others," Bradley Blakeman, deputy assistant to former President George W. Bush and professor of politics and public policy at Georgetown University, writes in a Fox News opinion piece calling for the U.S., which he says "has done more than its fair share for others since our birth as a nation," to "curtail our foreign aid."
Allergan, Inc. today announced the United States Food and Drug Administration (FDA) has approved BOTOX for injection for the treatment of urinary incontinence due to detrusor overactivity associated with a neurologic condition in adults who have an inadequate response to or are intolerant of an anticholinergic medication.
In today's headlines, a range of health policy news - including House hearings advanced by the GOP to further their repeal efforts and more reports about the budget deficit.
Data from four pivotal Phase III clinical trials demonstrate that linagliptin achieved statistically significant and sustained reductions in blood sugar as measured by hemoglobin A1c, fasting plasma glucose and postprandial glucose. Boehringer Ingelheim Pharmaceuticals, Inc. is investigating the dipeptidyl peptidase 4 inhibitor as an oral once-daily tablet, as monotherapy and combination therapy, to treat type 2 diabetes.
Many low-income countries are unlikely to reach the Millennium Development Goal (MDG) health targets set for 2015; the main reasons for this are fragile health systems and insufficient investments in understanding how to strengthen them, suggest authors of a Public Health article in this week's issue of THE LANCET.
› Verified 8 days ago
Arlene Paulson, LCSW-C Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 10605 Concord St Ste 207, Kensington, MD 20895 Phone: 301-231-9001 | |
Ms. Regina S Connor, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10500 Summit Ave, Kaiser Permanente Summit Behavioral Health Center, Kensington, MD 20895 Phone: 301-897-2500 | |
Reuben Rosen, LMSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3930 Knowles Ave Ste 200, Kensington, MD 20895 Phone: 240-801-5843 | |
Mrs. Elbereth Margaux Lunn, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10605 Concord St Ste 207, Kensington, MD 20895 Phone: 301-231-9001 | |
Ms. Karen Prince, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10400 Connecticut Ave, Suite 204, Kensington, MD 20895 Phone: 301-933-4588 | |
Melanie Rabkin, LCSW-C Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10605 Concord St, #207, Kensington, MD 20895 Phone: 301-651-4275 |